Predict your next investment

HEALTHCARE | Medical Facilities & Services / Specialized Healthcare Services
progressustherapy.com

See what CB Insights has to offer

Stage

Acquired | Acquired

Total Raised

$1.62M

About Progressus Therapy

Progressus Therapy is an education solutions provider, partnering with school districts to identify Speech-Language Pathology, Occupational Therapy, and Physical Therapy recruitment needs. Progressus clinicians in occupational therapy, speech language pathology and physical therapy support more than 30,000 children nationwide. The company is a nationwide provider of school-based therapy and early intervention services for school districts and communities across the country.

Progressus Therapy Headquarter Location

2701 North Rocky Point Drive Suite 650

Tampa, Florida, 33607,

United States

800-892-0640

Latest Progressus Therapy News

Invo Healthcare buys Progressus Therapy

Mar 28, 2016

Invo Healthcare buys Progressus Therapy March 28, 2016 Invo HealthCare Holdings, a portfolio company of Post Capital Partners, has acquired Progressus Therapy LLC. Financial terms weren’t announced. Tampa, Florida-based Progressus school-based therapy and early intervention services for school districts and communities. PRESS RELEASE JAMISON, Pa., March 24, 2016 /PRNewswire/ — Invo HealthCare Holdings (Invo) has announced its acquisition of Progressus Therapy, LLC (Progressus), creating the nation’s leading special education and early intervention services company. This combination, which officially closed on February 9, 2016, will significantly expand the school and community-based services provided by the organization. Both Invo and Progressus partner with school districts, charter schools and early intervention agencies to provide qualified special education and related services professionals. These services support a growing population of children from birth to 21 with special needs and focus on the following specialties: speech-language pathology, occupational and physical therapy, behavior analysis, teaching, nursing, social work and psychology. Together, Invo and Progressus provide services in more than 25 states with a staff of 1200+ skilled special education and early intervention professionals. “Through this acquisition we have united two highly-respected organizations to create the nation’s leading provider of special education and early intervention services,” said Anthony Manley, Chief Executive Officer. “Everything we do as an organization is driven by our mission to help children achieve in the classroom and beyond. With the addition of Progressus, we have significantly increased our capability to meet the growing needs of our partners and the children and families we serve.” Invo is a portfolio company of Post Capital Partners, a private equity firm based in New York. “When we partnered with Invo several years ago, we recognized a unique opportunity to help grow a great business that does so much to serve children with special needs and their families. As we bring Invo and Progressus together under the leadership of Anthony Manley and his team, we are significantly strengthening and growing our business while furthering its vital mission,” said Mitch Davidson, Managing Director of Post Capital Partners. About Invo HealthCare and Progressus Therapy Invo HealthCare Associates ( Progressus Therapy ( www.postcp.com ) is a private investment firm that makes both minority growth and control investments in businesses with repeat or recurring revenue models. Post Capital primarily employs an “Executive-First” deal sourcing and investment strategy in which it first identifies and partners with talented senior operating executives and then works proactively with those “Executive Partners” to identify investments. Post Capital pursues “Executive-First” platform searches, management buyouts and growth capital investments. Based in New York City, Post Capital invests a committed capital fund with top-tier institutional and sophisticated private investors. Logo – http://www.invohealthcare.com

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.